May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Flicker-Induced Retinal Vasodilatation in Patients With Diabetes, Patients With Systemic Hypertension and/or Hypercholesterolemia, and Healthy Control Subjects
Author Affiliations & Notes
  • B. Pemp
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
  • G. Weigert
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
  • G. Garhofer
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
  • K. Karl
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
  • U. Petzl
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
  • M. Wolzt
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
  • L. Schmetterer
    Medical University of Vienna, Vienna, Austria
    Department of Clinical Pharmacology,
    Center for Biomedical Engineering and Physics,
  • Footnotes
    Commercial Relationships  B. Pemp, None; G. Weigert, None; G. Garhofer, None; K. Karl, None; U. Petzl, None; M. Wolzt, None; L. Schmetterer, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2080. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Pemp, G. Weigert, G. Garhofer, K. Karl, U. Petzl, M. Wolzt, L. Schmetterer; Flicker-Induced Retinal Vasodilatation in Patients With Diabetes, Patients With Systemic Hypertension and/or Hypercholesterolemia, and Healthy Control Subjects. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2080. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : A number of studies indicate that patients with diabetes show an abnormal retinal vessel response to flicker stimulation. The mechanism behind this reduced vasodilator capacity is unclear. It has, however, been hypothesized that this phenomenon may be related to endothelial dysfunction, because the retinal flicker response has been shown to be nitric oxide dependent. In the present study we tried to gain more insight into this question by comparing the flicker responses in different groups with well established endothelial dysfunction.

Methods: : In the present study 20 patients with insulin dependent diabetes, no or mild non-proliferative diabetic retinopathy, and serum cholesterol levels < 250 mg/dl, 40 patients with systolic blood pressure between 140 and 159 mmHg and diastolic blood pressure between 90 and 99 mmHg and/or serum cholesterol plasma levels > 250 mg/dl and 20 healthy control subjects were included. The response of retinal arteries to flicker stimulation was measured using the Imedos Dynamic Retinal Vessel Analyzer. The retinal vessel response between the three groups was compared by an ANOVA model.

Results: : The response in retinal arterial diameter to flicker stimulation was 2.9 ± 0.6 % in patients with diabetes, 4.1 ± 0.4 % patients with systemic hypertension and/or hypercholesterolemia, and 7.6 ± 0.5 % in healthy control subjects (p < 0.001). There was, however, no difference in the flicker-induced vasodilatation between patients with diabetes and patients with systemic hypertension and/or hypercholesterolemia.

Conclusions: : The present study shows that different groups of patients with well established endothelial dysfunction have reduced flicker responses in the human retina. This supports the concept that flicker-induced vasodilatation is endothelium dependent.

Clinical Trial: : www.clinicaltrials.gov NCT00432029

Keywords: retina • diabetes • nitric oxide 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×